Cargando…
Neoadjuvant therapy and subsequent treatment in rectal cancer: balance between oncological and functional outcomes
Current practice of neoadjuvant therapy and total mesorectal excision (TME) in rectal cancer bears the weakness in systemic disease control and long-term functional outcomes. With increasing concerns of the balance between cure and quality of life, new strategies are developed to better oncological...
Autores principales: | Qin, Qiyuan, Wang, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Society of Coloproctology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768820/ https://www.ncbi.nlm.nih.gov/pubmed/31583321 http://dx.doi.org/10.23922/jarc.2017-049 |
Ejemplares similares
-
Good response to neoadjuvant chemoradiotherapy predicts good oncological outcome in locally advanced rectal cancer
por: Zhang, Chi, et al.
Publicado: (2019) -
Clinical outcome of neoadjuvant chemoradiation in rectal cancer treatment
por: Suwanthanma, Weerapat, et al.
Publicado: (2021) -
Effect of Interval between Neoadjuvant Chemoradiotherapy and Surgery on Oncological Outcome for Rectal Cancer: A Systematic Review and Meta-Analysis
por: Wang, Xiao-Jie, et al.
Publicado: (2016) -
Outcomes in Patients Treated by Laparoscopic Resection of Rectal Carcinoma After Neoadjuvant Therapy for Rectal Cancer
por: Rezvani, Masoud, et al.
Publicado: (2007) -
Neoadjuvant tyrosine kinase inhibitors in rectal gastrointestinal stromal tumours: a provision for enhanced oncological and functional outcomes
por: Yong, Zachary Zihui, et al.
Publicado: (2021)